![]() |
home | contact us |
![]() |
Faculty
Last Updated: 1 June 2012|
Peter Libby, M.D. – Program co-chair Mallinckrodt Professor of Medicine Harvard Medical School Jean-Claude Tardif, M.D. – Program co-chair Director, Research Center Montreal Heart Institute Eric Abadie, M.D. Director, Therapeutics Evaluation, AFSSAPS European Medicines Agency (EMEA) Christine Albert, M.D., MPH Director, Center for Arrhythmia Prevention Harvard Medical School Boston, MA Jonathan Allis, M.D. Global Head of Imaging GE Healthcare Diagnostics Todd Anderson, M.D. Director, Foothills Hospital Naomi Aronson, Ph.D. Executive Director Technology Evaluation Center Blue Cross and Blue Shield Association Chicago, IL Robert S. Balaban, M.D., Ph.D. National Heart, Lung and Blood Institute National Institutes of Health Christie Ballantyne, M.D. Director, Ctr. for Cardiovascular Disease Prev. Baylor College of Medicine Ruth Barrington, PhD, Chief Executive Officer, Molecular Medicine Ireland, Dublin Ireland Frank Barry, PhD, Director, National Centre for Biomedical Engineering Science, National University Ireland, Galway Thomas Barry, PhD, Molecular Diagnostics Research Group, National University of Ireland, Galway Philip Barter, M.D. Professor of Medicine University of Sydney Russell Basser, M.D. Global Director of Clinical Development CSL, Ltd. Philippe Bedard, M.D. Asst. Professor Princess Margaret Hospital, Toronto Colin Berry, BSc., M.D., Ph.D. Cardiovascular MRI / CV Intervention Program NHLBI, National Institutes of Health Donald M. Black, MBA, M.D. Global Head of Research and Development General Electric Healthcare President, Trialynx Inc. Sandra Black, M.D. Brill Chair in Neurology Sunnybrook Health Sciences Centre, Toronto Melanie Blank, M.D. Division of Cardiovascular and Renal Products CDER, FDA Eric P. Brass, M.D., Ph.D. Professor of Medicine Harbor-UCLA Medical Center H. Bryan Brewer, Jr., M.D. Director of Lipoprotein and Atherosclerosis Research MedStar Research Institute Greg Brown, M.D., Ph.D. Proffessor of Medicine University of Washington David G. Brown, Ph.D. NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems US FDA W. Virgil Brown, M.D. Charles Howard Candler Professor of Medicine Emory University School of Medicine Atlanta, GA Michael A. Browlee, MD Albert Einstein College of Medicine Diarmuid Cahalane, Founder of Open Innovation Partners Ltd, Cork Ireland Dolores Cahill, PhD, Professor of Translational Science, University College Dublin, Ireland Gloria Crispino, PhD,Clinical Trial Statistician , Institute of Technology Tallaghat , Dublin, Ireland Robert M. Califf, M.D. Vice Chancellor for Clinical Research Director, Duke Translational Medicine Institute Durham, NC Gregory Campbell, Ph.D. Director, Division of Biostatistics US FDA, CDRH Christopher Cannon, M.D. Associate Prof. of Medicine, Brigham and Women's Hospital Gao Chenyan, M.D. Director of Division VII Center of Drug Evaluation, China SFDA Beijing, China Eric Colman, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA Carolyn C. Compton, M.D., Ph.D. Director, Office of Biorepositories and Biospecimen Research (OBBR) National Cancer Institute, National Institutes of Health Douglas Cowart, Pharm.D. Association of Clinical Research Organizations Janet Dancey, M.D. Director, Clinical Translational Research NCIC Clinical Trials Group, Ontario Hayes Dansky, M.D. Director, Cardiovascular Disease Merck Research Laboratories Michael Davidson, M.D. Director of Preventive Cardiology University of Chicago School of Medicine Jill Davies, M.Sc, Genetic Counsel Program Director, MedCan Clinic Jean Davignon, M.D. Director Hyperlipidemia and Athero Research Clinical Research Institute of Montreal Professor of Medicine, University of Montreal Montreal, Quebec John Deanfield British Heart Foundation Clarissa Desjardins, PhD, CEO Center of Excellence in Personalized Medicine James De Lemos, M.D. Associate Professor and CCU Director University of Texas-Southwestern Medical School Marcelo Di Carli, M.D. Chief, Nuclear Medicine Brigham and Women's Hospital Pamela S. Douglas, M.D. Director, DCRI CV Imaging Program Duke University Medical Center Elizabeth Eisenhauer, M.D. Professor, Dept. of Oncology Queens Univ. Canadian Cancer Research Alliance Benjamin Eloff, Ph.D. Office of Scientific and Medical Programs Office of the Commissioner, US FDA Zahi A. Fayad, Ph.D. Professor, Departments of Radiology and Med. Mount Sinai School of Medicine Mark Ferguson, PhD, Director General, Science Foundation Ireland Giora Feuerstein, MD Head, Discovery Translational Medicine Wyeth Research Uri Frank, PhD, National Centre for Biomedical Engineering Science, National University of Ireland, Galway Felix W. Frueh, Ph.D. Vice President, R&D Personalized Medicine Medco Health Solutions, Inc. Brandon D. Gallas, PhD,NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems US FDA
|
Jean-Jacques Garaud, M.D. Head of Global Drug Development F. Hoffmann-La Roche Ltd Alan J. Garber, M.D., Ph. D. Professor, Medicine, Biochemistry, Molecular and Cellular Biology Baylor College of Medicine Houston, TX Marcie Glicksman, Ph.D. Asst. Professor, Neurology Brigham and Women's Hospital Anne Goodbody, PhD, Director Ontario Institute for Cancer Research Federico Goodsaid, Ph.D. Office of Clinical Pharmacology Center for Drug Evaluation and Research, US FDA Mark Grant, M.D. Senior Scientist, Technology Evaluation Center Blue Cross Blue Shield Association Steven Gutman, M.D. Director, Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiologic Health, FDA Silver Spring, MD Rory Hachamovitch, M.D. Department of Medicine University of Southern California Los Angeles, CA Robert Harrington, M.D. Duke University Patricia P. Harlow, Ph.D. Division of Cardiovascular and Renal Drug Products US FDA, CDER Thomas Hatsukami, M.D. Vascular Surgery, Washington University Stan Hazen, M.D. Cleveland Clinic Foundation Jay Heinecke, M.D. Professor of Medicine University of Washington Therese Heinonen, D.V.M. Associate Director, Medical and Science Affairs, Montreal Heart Institute Coordinating Center Chris Howard, Solution Architect, IBM Innovation Centre, Dublin, Ireland Thomas Hudson, M.D. President and Scientific Director Ontario Institute for Cancer Research Seigo Izumo, M.D., Ph.D. Vice President and Global Head CV Research Novartis Institute for Biomedical Research Ilan Irony M.D. Clinical Team Leader DMEP, OND, CDER, US FDA Hylton Joffe, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA Dominique Johnson, Ph.D. Director Montreal Heart Institute Coord. Center Lokesh Joshi, PhD,Director, Alimentary Glycoscience Research Clusher, National University Ireland, Galway Koen Kas, PhD, Professor, University Ghent, CSO, Pronota, Ghent, Belgium John Kastelein Chair, Genetics in CV Disease, University of Amsterdam Cormac Kilty, PhD, Chief Technical Officer, EKF, Diagnostics, London England Agnes Klein, M.D. Director, Ctr. for Eval. Of Radiopharm. And Biotherapeutics, Health Canada Michael Klimas, Ph.D. Executive Director, Imaging Franchise Lead Merck & Co., Inc. Wolfgang Koenig, M.D. Professor of Medicine and Cardiology University of Ulm Medical Center, Ulm Germany Reijo Laaksonen, MD, PhD, Chief Medical Officer and Co-Founder, Zora Biosciences, Espoo Finland Hanno Langen, PhD, Global Head of Protein and Metabolite Technologies, Hoffman-LaRoche, Basel Switzerland Lewis Kuller, M.D. Chair Epidemiology, University of Pittsburgh Jeff Leiden, M.D., Ph.D. Managing Director Clarus Ventures Lawrence Leiter, M.D. Head, Endocrinology and Metabolism St. Michael's Hospital, Toronto Claude Lenfant, M.D. Director, NIH, NHLBI Daniel Levy, MD Director, Framingham Heart Study Director, Center for Population Studies National Heart, Lung, & Blood Institute Bethesda, MD Robyn Lim, Ph.D. Scientific Advisor Office of Legislative and Regulatory Modernization Health Canada João A.C. Lima, M.D. Assoc. Prof. of Med., Rad. and Epidemiology Johns Hopkins University Ray Lipicky, M.D. Former Director, Cardio-Renal, FDA Peter Liu, M.D.,Scientific Director Canadian Institutes of Health Research Klas Malmberg, M.D., PhD. Karolinska Institute Elizabeth Mansfield, Ph.D. Senior Policy Analyst, Office of In Vitro Diag. Device Eval. and Safety, CDRH, USFDA Bruce McManus, M.D., Ph.D. Professor and Director, The James Hogg iCAPTURE Centre University of British Columbia - St. Paul's Hospital Scientific Director, The Heart Centre - Providence Health Care Vancouver, British Columbia David O. Meltzer, M.D., Ph.D. Director of the Center for Health and Social Sciences Department of Medicine and Dept. of Economics University of Chicago Chicago, IL George A. Mensah, M.D. National Ctr. for Chronic Disease Prevention and Health Prom.Centers for Disease Control and Prevention Michele Mercuri, M.D., Ph.D. Head Pharma Scientific Review Committee Novartis Pharmaceuticals Corp. Pierre Meulien, PhD, President and Chief Executive Officer, Genome Canada George Mills, M.D. Vice President, Medical Imaging Consulting Perceptive Informatics Gary F. Mitchell, M.D. Cardiovascular Engineering, Inc. Waltham, MA Jacques Mizrahi, M.D. Head, Metabolic Diseases F. Hoffmann-LaRoche Vincent Mooser, M.D. Clinical Pharmacology and Disc. Med. GlaxoSmithKline C. Daniel Mullins, PhD. Professor, Pharmacoeconomics University of Maryland Elizabeth Nabel, M.D. Director, NHLBI, NIH Ilaria Nardello, National University of Ireland, and National Coordinator, the Marine Institute, Ireland Steve Nissen, M.D. Director, Cleveland Clinic Foundation Minh Nguyen, M.D. University of Florida Christopher O'Donnell, M.D. Senior Advisor, Genome Research NHLBI, National Institutes of Health Daniel O'Leary, M.D. Chairman Radiology, New England Medical Center |
Patrick O'Mahony, DVM, MBA Executive Director,Irish Medicnes Board, Chairman, European Medicines Agency (EMA), Dublin, Ireland Brian O’Neill, PhD, Manager of Life Sciences, Enterprise Ireland David Orloff, M.D. Executive Director, Reg Affairs Medpace Inc. Abhay Pandit, PhD, Director, Network of Excellence for Functional Biomaterials, National University Ireland, Galway Mary Parks, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA Gerard Pasterkamp, MD, PhD, Chief Scientific Officer, Cavadis, Experimental Cardiology Laboratory, University Medical Center Utrecht, The Netherlands Michael Perelman, M.D. Vice President, Global Project Mgmt Schering-Plough Research Institute Marc Pfeffer, M.D., Ph.D. Professor of Medicine Harvard Medical School Boston, MA Michael S. Phillips, Ph.D. Director of Pharmacogenomics Genome Quebec Montreal, Quebec Hubert Pouleur, MD, PhD, Vice President, Cardiovascular-Metabolic Disease Strategy, Pfizer Inc. New York, NY- USA Robert Powell, PharmD Director, Pharmacometrics Office of Clinical Pharmacology Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring, MD Daniel Rader, M.D. University of Pennsylvania Paolo Raggi, M.D. Director, Preventive Cardiology, Tulane Joel Raichlen, M.D. Senior Director, Clinical Research Astra-Zeneca Gurvaneet Randhawa, M.D. Center for Outcomes and Evidence Agency for Healthcare Research and Quality Patricia Reilly, Member of the Cabinet of Maire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, Dublin, Ireland Paul M. Ridker, M.D. Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital Dwaine Rieves, M.D. Director, Medical Imaging Center for Drug Evaluation and Research, US FDA John Rioux, Ph.D. The Lab of Genetics and Genomic Med of Inflam., Montreal Heart Institute Robert Roberts M.D. President and CEO University of Ottawa Heart Institute Jean Rouleau, M.D. Dean of Medicine University of Montreal Army E. Rudolph, Ph.D. Director, Glob. Med CV Metabolic Endocrine Pfizer, Inc. Kerry-Anne Rye, Ph.D. Head, Lipid Research Group The Heart Research Institute, Sydney, AU Philip Sager, M.D. Chief Medical Officer CardioDx, Inc. William J. Sasiela, Ph.D. Chief Medical Officer Aegerion Pharmaceuticals, Inc. Ernst Schaefer, M.D. Director, Lipid Metabolism Laboratory Tufts University Boston, MA Patrice Sarrizin, Ph.D. Senior Scientific Evaluator In Vitro Diagnostic Devices Health Canada Daniel Schultz, M.D. Director, Center for Devices and Radiological Health US Food and Drug Administration Rockville, MD Sonia Skarlatos Ph.D. Deputy Director Devision of Cardiovascular Sciences National Heart, Lung, and Blood Institute, NIH David Smalley, Ph.D. Assistant Professor Cardiovascular Research Center University of Virginia Carl Sparrow, Ph.D. Director, Lipid Biochemistry Merck Research Laboratories J. David Spence, M.D. Director, Stroke Prevention and Athero Research Centre Robarts Research Institute London, Ontario, CANADA Ton van der Steen, Ph.D. Biomedical Tech in Cardiologym Thorax Center, Rotterdam George Steiner, M.D. University of Toronto Norman Stockbridge, M.D. Division of Cardio-Renal, Center for Drug Evaluation and Research, US FDA Erik Stroes, M.D., Ph.D. Department of Vascular Medicine Academic Medical Center, Amsterdam Anders Svensson, M.D. Head of Clinical Development - Metabolism F. Hoffman-LaRoche, Ltd. Alan Tall, M.D. Professor of Medicine Columbia University Allen Taylor, M.D. Chief, Cardiology Service Walter Reed Army Medical Center Ahmed Tawakol, M.D. Professor of Medicine Massachusetts General Hospital Robert Temple, M.D. Director, Office of Medical Policy US FDA Douglas C. Throckmorton, M.D. Deputy Center Director, Center for Drug Evaluation and Research, US FDA Paula R. Trumbo, Ph.D. Team Leader, Nutrition Science Eval. Center for Food Safety and App. Nutrition, US FDA Roger Ulrich, Ph.D. Chief Development Officer Callistoga Pharmaceuticals Spiros Vamvakas, Head of Section for Scientific Advice, European Medicines Agency Karin Wahlander, MD,PhD, Vice President for Translational Science, Astra Zeneca , Sweden John Wagner, MD, Ph.D. Director, Clinical Pharmacology Merck & Co., Inc. David Waters, M.D. Chief, Cardiovascular Medicine University of California, San Francisco G. Russell Warnick, M.S., MBA Chief Scientific Officer Berkeley HeartLab, Inc. Ralph Weissleder, M.D., Ph.D. Director, Center for Molecular Imaging Research Professor of Radiology, Harvard Medical School Boston, MA James J. Zhang, M.D., Ph.D., MBA Global Clinical Development Siemens Molecular Imaging, Inc. Siemens Medical Solutions USA Bram Zuckerman, M.D. Director, Center for Devices and Radiological Health, US FDA |